Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autocrine secretion--10 years later.

M B Sporn1, A B Roberts

  • 1National Cancer Institute, Bethesda, Maryland.

Annals of Internal Medicine
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardioprotective actions of transforming growth factor-β.

Trends in cardiovascular medicine·2011
Same author

Functional redundancy of TGF-beta family type I receptors and receptor-Smads in mediating anti-Mullerian hormone-induced Mullerian duct regression in the mouse.

Biology of reproduction·2008
Same author

Smad3 deficiency inhibits v-ras-induced transformation by suppression of JNK MAPK signaling and increased farnesyl transferase inhibition.

Oncogene·2007
Same author

Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion.

Developmental biology·2002
Same author

Meeting report: signaling schemes for TGF-beta.

Science's STKE : signal transduction knowledge environment·2001
Same author

Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis.

Advances in cancer research·2001
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Autocrine secretion involves peptide growth factors regulating tissue balance. Aberrant signaling contributes to diseases like cancer and arthritis, offering therapeutic targets for prevention and treatment.

Area of Science:

  • Cell Biology
  • Molecular Medicine
  • Immunology

Background:

  • Autocrine secretion is a key mechanism where cells release signaling molecules that act on themselves.
  • Peptide growth factors, or cytokines, function as local autocrine and paracrine mediators crucial for maintaining tissue homeostasis.
  • Dysregulation of these signaling pathways is implicated in the pathogenesis of various chronic inflammatory and fibrotic diseases.

Purpose of the Study:

  • To review the concept of autocrine secretion and its biological roles.
  • To explore the involvement of autocrine signaling in disease pathogenesis, including cancer and inflammatory conditions.
  • To discuss the potential of targeting autocrine pathways for novel therapeutic strategies.

Main Methods:

  • Literature review of autocrine signaling mechanisms.

Related Experiment Videos

  • Analysis of the role of cytokines in tissue homeostasis and disease.
  • Exploration of biotechnological and pharmacological approaches for therapeutic intervention.

    • Main Results:

    • Autocrine secretion is fundamental to cellular communication and tissue regulation.
    • Aberrant cytokine expression and signaling are linked to the development and progression of diseases such as cancer, atherosclerosis, and rheumatoid arthritis.
    • These molecular and cellular dysfunctions present opportunities for therapeutic development.

    Conclusions:

    • Understanding autocrine secretion provides insights into disease mechanisms.
    • Targeting cytokine synthesis and activity offers promising avenues for preventing and treating complex diseases.
    • Biotechnology and pharmacology are key to developing these novel therapeutic interventions.